Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
UMB Financial
UMBF
$11.5B
| $13.5M | ﹤0.01% |
159,933
+33,322
| +26% | +$3.02M |
|
2627
S&T Bancorp
STBA
$1.81B
| $13.5M | ﹤0.01% |
459,779
+41,809
| +10% | +$1.26M |
|
|
UNVR
2628
DELISTED
Univar Solutions Inc.
UNVR
| $13.4M | ﹤0.01% |
591,292
-296,158
| -33% | -$7.44M |
|
|
GLQ
2629
Clough Global Equity Fund
GLQ
$156M
| $13.4M | ﹤0.01% |
1,956,988
+233,714
| +14% | +$2.06M |
|
|
CHI
2630
Calamos Convertible Opportunities and Income Fund
CHI
$1.08B
| $13.4M | ﹤0.01% |
1,390,989
+8,088
| +0.6% | +$94.3K |
|
2631
Northwest Bancshares
NWBI
$2.31B
| $13.4M | ﹤0.01% |
994,066
+9,574
| +1% | +$133K |
|
2632
Cavco Industries
CVCO
$4.66B
| $13.4M | ﹤0.01% |
65,203
+9
| +0% | +$2.13K |
|
2633
BlackRock Floating Rate Income Strategies Fund
FRA
$388M
| $13.4M | ﹤0.01% |
1,218,195
+93,151
| +8% | +$1.11M |
|
2634
AXIS Capital
AXS
$7.4B
| $13.4M | ﹤0.01% |
272,614
+17,271
| +7% | +$915K |
|
2635
Northern Oil and Gas
NOG
$2.63B
| $13.4M | ﹤0.01% |
488,789
+146,388
| +43% | +$4.13M |
|
2636
FuelCell Energy
FCEL
$1.81B
| $13.4M | ﹤0.01% |
130,761
-11,392
| -8% | -$1.36M |
|
|
CCRN
2637
DELISTED
Cross Country Healthcare
CCRN
| $13.4M | ﹤0.01% |
471,362
-6,828
| -1% | -$176K |
|
|
SAGE
2638
DELISTED
Sage Therapeutics
SAGE
| $13.3M | ﹤0.01% |
340,715
-232,585
| -41% | -$8.99M |
|
2639
Pediatrix Medical
MD
$2.16B
| $13.3M | ﹤0.01% |
807,169
-48,308
| -6% | -$972K |
|
2640
Mirion Technologies
MIR
$3.95B
| $13.3M | ﹤0.01% |
1,783,564
+86,936
| +5% | +$612K |
|
2641
Minerals Technologies
MTX
$2.26B
| $13.3M | ﹤0.01% |
269,289
+124,959
| +87% | +$7.6M |
|
2642
NeoGenomics
NEO
$2.05B
| $13.3M | ﹤0.01% |
1,544,640
+227,032
| +17% | +$2.25M |
|
2643
AppFolio
APPF
$7.15B
| $13.3M | ﹤0.01% |
126,993
+1,237
| +1% | +$126K |
|
2644
Par Pacific Holdings
PARR
$4.02B
| $13.3M | ﹤0.01% |
810,071
-52,630
| -6% | -$893K |
|
2645
iShares MSCI Switzerland ETF
EWL
$2.21B
| $13.3M | ﹤0.01% |
354,192
-25,396
| -7% | -$1.05M |
|
2646
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$433M
| $13.3M | ﹤0.01% |
918,339
+269,170
| +41% | +$4.25M |
|
2647
Cerence
CRNC
$403M
| $13.2M | ﹤0.01% |
841,243
+4,729
| +0.6% | +$106K |
|
2648
Rapid7
RPD
$866M
| $13.2M | ﹤0.01% |
308,580
-30,244
| -9% | -$1.87M |
|
2649
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64M
| $13.2M | ﹤0.01% |
422,639
+25,032
| +6% | +$872K |
|
2650
BGC Group
BGC
$5.29B
| $13.2M | ﹤0.01% |
4,209,904
-426,662
| -9% | -$1.65M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.